Dr. Deepak Chhabra

MS. (Bom), DNB, M.R.C.S. (Edin. UK)

Book Appointment

Professional affiliations of Dr. Chhabra include:

  • IHPBA (International Hepato-Pancreato-Biliary Association)
  • Member of Indian Chapter of IHPBA
  • Member of the A-PHPBA (Asia-Pacific Hepato-Pancreato-Biliary Association)
  • Member of the Royal College of Surgeons of Edinburgh, UK
  • Association of Medical Consultants, Mumbai

About Doctor

Dr. Deepak Chhabra is a consultant Surgical Oncologist with an extensive experience in cancer surgeries. After completing his Masters in Surgery (from the prestigious T.N.Medical College and B.Y.L Nair Hospital in Mumbai) and Diplomat from the National Board of Examinations, he subsequently received his specialist oncosurgical training at Mumbai.

 

During his training of cancer surgeries, he also passed the Membership examination of the Royal College of Surgeons of Edinburgh, UK. He has a Fellowship in GI surgical Oncology and has been associated with the Department of Surgical Oncology at Lilavati Hospital, Mumbai for more than 10 years.

 

In order to become further experienced, he went to Nagoya University, Japan and trained himself in complex Hepato-Pancreato-Biliary surgeries under the expert guidance of Prof. Yuji Nimuraa pioneer in the field of complex liver surgeries. His research work on gallbladder cancers was in the award paper sessions at the World Congress of IHPBA in 2008.

An International Collaborative Research Study on “Heavy Metals in Gallbladder Cancers” was initiated at Nagoya with the aim of early detection and treatment of gallbladder cancers in India.

He is presently attached to and consulting at the Lilavati Hospital (Bandra), Hiranandani Hospital (Powai), and Criticare Hospital, (JVPD). He is also a visiting consultant at the Asian Institute of Oncology (SA-AIO) and Breach Candy Hospital.

He has published many papers in National & International Peer review journals and has contributed to book chapters as well. Many articles have been presented by him at various national and international conferences. He has been an invited speaker for many surgical oncology discussions in Mumbai and rest of India. He has been a co-investigator for various research trials related to gastrointestinal cancers and neuroendocrine tumors of gastrointestinal system. He was the first clinical co-ordinator of the Asia-Pacific Neuroendocrine tumor registry (AP-NET registry) in India.

Dr. Deepak Chhabra is updated with most of the current advanced technologies in the field of cancer surgeries. His special interest is in treatment of gastrointestinal and hepato-pancreato-biliary cancers (cancer of pancreas, liver, bile-ducts and gallbladder). Major gastric (stomach and food pipe) resections, liver resections, radiofrequency ablation for liver tumors, pancreatic resections, colonic (intestine) resections and sphincter saving surgeries for low rectal cancers are being performed regularly by him. Breast cancer surgeries, utero-ovarian cancer surgeries and chemotherapy port placements are a routine part of his practice as well.

Though combined modes of treatment are necessary for most of the cancers, Dr. Chhabra strongly believes that an aggressive surgery is the backbone of treatment for all solid organ cancers.

Vision

This vision CAN be accomplished

“TO DEFEAT CANCER”

CANCER: A word that can run shivers down the spine….an uninvited entity that disrupts our peace of life. But remember, its only a word and not a sentence that has a full stop.

Let’s Fight it, Let’s resist it, Let it not stop us, Let it not dampen our spirits, Let’s DEFEAT CANCER.

Cancer may be strong, but we CAN be stronger
The vision to defeat cancer…

  • If people know how to reduce their risk of cancer:
  • If “No Smoking” is accepted as a motto
  • If people understand and accept screening methods so that cancer can be diagnosed early
  • If people with cancer get the information they need
  • If there is an access to better treatment at economical costs
  • And most importantly if there is a POSITIVE ATTITUDE towards fighting cancer.